Deirdre P. Connelly
Deirdre Connelly is retired from the role of president, North America Pharmaceuticals for GlaxoSmithKline (GSK). She was a member of the company’s global Corporate Executive Team and co-chaired, along with GSK’s Chairman, Research and Development, its Portfolio Management Board.
Prior to her tenure at GSK from 2009 to 2015, Connelly was with Eli Lilly and Company, where she had been president of Lilly USA. During her 26-year career with Eli Lilly, she held a variety of executive positions, including senior vice president of human resources for the corporation, as well as vice president of human resources for pharmaceutical operations.
Connelly began her career in the pharmaceutical industry as a sales representative with Lilly in San Juan, Puerto Rico. She moved to marketing and then joined Lilly’s international management development program. Connelly was named national sales manager for the Puerto Rico affiliate and later became director of sales and marketing for the Caribbean Basin Region. She also served as general manager for Eli Lilly Puerto Rico. Later, she was named executive director of global marketing for Evista, and leader of the woman’s health business unit in the U.S.
For nine consecutive years (2006-2014), Connelly was recognized by Fortune magazine as one of the 50 most powerful women in business. In 2010, she was named Woman of the Year by the Healthcare Businesswomen's Association. In 2008, she was appointed to the President’s Commission on White House Fellowships and helped select the White House Fellows, a prestigious annual program that fosters leadership and public service.
Born in San Juan, Connelly earned a bachelor's degree in Economics and Marketing from Lycoming College. She also graduated from Harvard University's Advanced Management Program. In 2013, she was appointed to the Harvard University Public Health Policy Council. Connelly also serves as a member of the Board of Directors for Macy’s, Inc. and Genmab A/S.